Wednesday, May 18, 2022
wellness India Expo
Home Tags Sun Pharma

Tag: Sun Pharma

Dr. Bushra Ateeq wins Sun Pharma Science Foundation Research Award-2021

An IIT Kanpur professor, Dr. Ateeq’s research interest involves exploration of the genetic and epigenetic changes that initiate cancer and its progression

Sun Pharma to set up an end to end manufacturing facility...

The opening of this facility will lead to the creation of more jobs and will contribute to the enhancement of the industrial sector in the state.

Sun Pharma Advanced Research signs licensing deal with Biomodifying LLC

SPARC enters into a licensing agreement with Biomodifying to acquire exclusive rights for antibody against unique oncology target

National Doctors’ Day: Sun Pharma’s ‘Sunkalp’ initiative for doctors & their...

As a special tribute, announces various initiatives for the welfare of doctors, their families and the community....................

Sun Pharma to market Ferring Pharmaceuticals’s obstetric drug ‘CARITEC’ in India

As per the company, CARITEC is an innovative obstetric drug for preventing post-partum hemorrhage. It is a Room Temperature Stable (RTS) formulation of Carbetocin and addresses limitations in refrigeration and cold-chain transportation.......................

DigiHealth to invest in developing a world-class supply chain & distribution...

The investment has been made with a view to develop a world-class pharmaceutical supply chain & distribution IT ecosystem and support the government’s National Digital Health Mission.............................

Sun Pharma launches website for its long-term care portfolio in US

New website highlights the efficacy and safety profile for each product, while also educating healthcare providers and patients about our intent to mitigate risks associated with improper medication manipulation......................

Sun Pharma initiates Phase 2 clinical trial of Psoriasis drug

SCD-044 is also being evaluated in other autoimmune disorders and Phase 2 studies for other indications like atopic dermatitis, are also expected to be initiated soon......................

Sun Pharma announces 5-year sustained efficacy & safety results for its...

ILUMYA is the first IL-23 inhibitor to complete five years of study based on a pooled analysis of two Phase 3 efficacy and safety extension trials in moderate-to-severe plaque psoriasis.......................

Sun Pharma launches FluGuard for moderate COVID-19 patients at Rs 35...

Sun Pharma has launched FluGuard® (Favipiravir 200 mg) at a comparatively economical price of Rs 35 per tablet, for the treatment of mild to moderate cases of Covid-19 in India...............